Problem statement: Answer the MCQ question.
Query: Which compound exhibits a -28.429% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a COc1ccc(CNC(=O)CN2C(=O)NC(C)(c3ccc(Cl)cc3)C2=O)cc1
b Cn1c(SCC(=O)N/N=C/C=C\c2ccco2)nc2ccccc21
c O=S1(=O)CC(O)C(NCCCO)C1
d Cn1ncc2c(N3CCN(c4ccccc4F)CC3)ncnc21
Answer: d. Cn1ncc2c(N3CCN(c4ccccc4F)CC3)ncnc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1ncc2c(N3CCN(c4ccccc4F)CC3)ncnc21
Cn1ncc2c(N3CCN(c4ccccc4F)CC3)ncnc21
4-[4-(2-fluorophenyl)piperazin-1-yl]-1-methylpyrazolo[3,4-d]pyrimidine